Localized bilateral perirenal fibrosis, a rare cause of idiopathic retroperitoneal fibrosis
Abstract
Background: Idiopathic retroperitoneal fibrosis is an infrequent process of unknown aetiology characterised by fibrous tissue proliferation in the retroperitoneum. Even less frequent is a localized form of this disease by a proliferation of fibrous tissue around single or both kidneys.
Case report: We describe a case of 46-year old man in whom medical management was started for accidentally discovered arterial hypertension, which turned out to be difficult to control. During diagnostic work-up of hypertension, an abdominal ultrasound was obtained a year later demonstrating slight bilateral caliectasis without obvious visible cause for it. Laboratory exams have shown significantly impaired renal function, normocytic anaemia, slightly higher sedimentation rate, increased CRP and normal urinalysis. Nephrologist has decided for hospitalisation during which magnetic resonance imaging was performed showing a few mm wide tissue coats surrounding both kidneys with fluid lying between the coat and kidney capsule. A biopsy of perirenal mass has confirmed a dense cellular lesion consisted of interweaved fascicles of spindle-shaped cells. After exclusion of tumours and other causes, a diagnosis of retroperitoneal fibrosis was confirmed. Clinical picture and laboratory data corresponded to idiopathic form of this disease. A treatment with tamoxifen was started after patient refused treatment with methylprednisolone. During tamoxifen monotherapy, there was gradual significant improvement of general symptoms, notable decline in inflammation markers, improvement of anaemia, normalisation of kidney function, and normalisation of blood pressure.
Conclusion: Retroperitoneal fibrosis is still an obscure and multifaceted disease. A proper selection of diagnostic methods is the key to correct and fast diagnosis as well as good grounding for proper treatment.
Downloads
References
Gilkeson GS, Allen NB. Retroperitoneal fibrosis: a true connective tissue disease. Rheum Dis Clin North Am 1996; 22: 23–38.
Uibu T, Oska P, Auvinen A, Honkanen E, Metsarinne K, Saha H, et al. Asbestos exposure as a risk factor for retroperitoneal fibrosis. Lancet. 2004; 363: 1422-6.
van Bommel EF, Jansen I, Hendriksz TR, Aarnoudse AL. Idiopathic retroperitoneal fibrosis: prospective evaluation of incidence and clinicoradiologic presentation. Medicine (Baltimore). 2009; 88:193-201.
Vaglio A, Salvarani C, Buzio C. Retroperitoneal fibrosis. Lancet. 2006; 367: 241-51.
Parums DV. The spectrum of chronic periaortitis. Histopathology 1990; 16: 423–31.
Vaglio A, Buzio C. Chronic periaortitis: a spectrum of diseases. Curr Opin Rheumatol 2005; 17: 34–40.
Vaglio A, Corradi D, Manenti L, Ferretti S, Garini G, Buzio C. Evidence of autoimmunity in chronic periaortitis: a prospective study. Am J Med 2003; 114: 454–62.
Zen Y, Onodera M, Inoue D, Kitao A, Matsui O, Nohara T, et al. Retroperitoneal fibrosis: a clinicopathologic study with respect to immunoglobulin G4. Am J Surg Pathol 2009; 33: 1833-9.
Clevenger JA, Wang M, MacLennan GT, Montironi R, Lopez-Beltran A, Cheng L. Evidence for clonal fibroblast proliferation and autoimmune process in idiopathic retroperitoneal fibrosis. Human Pathol 2012; doi:10.1016/j.humpath.2012.01.012.
Khosroshahi A, Carruthers MN, Stone JH, Shinagore S, Sainani N, Hassrjian P, Desphande V. Rethinking Ormond’s disease. “Idiopathic” retroperitoneal fibrosis in the era of IgG4-related disease. Medicine 2013; 92: 82-91.
Swartz RD. Idiopathic retroperitoneal fibrosis: a review of the pathogenesis and approaches to treatment. Am J Kidney Dis 2009; 54: 546-53.
Corradi D, Maestri R, Palmisano A, Bosio S, Greco P, Manenti L, et al. Idiopathic retroperitoneal fibrosis: clinicopathologic features and differential diagnosis. Kidney Int 2007; 72: 742-53.
Kermani TA, Crowson CS, Achenbach SJ, Luthra HS. Idiopathic retroperitoneal fibrosis: A retrospective review of clinical presentation, treatment, and outcomes. Mayo Clin Proc 2011; 86: 297-303.
Marcolongo R, Tavolini IM, Laveder F, Busa M, Noventa F, Bassi P, Semenzato G. Immunosuppressive therapy for idiopathic retroperitoneal fibrosis: a retrospective analysis of 26 cases. Am J Med 2004; 116: 194-7.
Fernandez-Codina A, Martinez-Valle F, Castro-Marrero J, DeTorres I, Vilardell-Torres M, Ordi-Ros J. Idiopathic retroperitoneal fibrosis: a clicopathological study in 24 Spanish cases. Clin Rheumatol 2013; 32: 889-93.
Mavragani CP, Voulgarelis M. Retroperitoneal fibrosis and c-ANCA positivity. Clin Rheumatol 2007; 26: 115–6.
vam Bommel EFH, Brouwers AJWB, Makkus ACF, van Vliet ACM. Retroperitoneal fibrosis and p-ANCA-associated polyarteritis nodosa: coincidental or common etiology? Europ J Intern Med 2002; 13: 392-5.
Piccoli GB, Consiglio V, Arena V, Pelosi E, Anastasios D, Ragni F, et al. Positron emission tomography as a tool for the “tailored” management of retroperitoneal fibrosis: a nephro-urological experience. Nephrol Dial Transplant 2010; 25: 2603-10.
Ayuso JR, Garcia-Criado A, Caralt TM, Ayuso C, Torras A, Ribalta T. Atypical retroperitoneal fibrosis: MRI findings. Eur Radiol 1999; 9: 937-9.
Jendro MC, Zeidler H, Rosenthal H, Haller H, Schwarz A. Improvement of Erdheim–Chester disease in two patients by sequential treatment with vinblastine and mycophenolate mofetil. Clin Rheumatol 2004; 23: 52–6.
Sofiane B, Arnaud D, Olivier B, Arnaud L, Pignot G. Retroperitoneal fibrosis: An atypical presentation of localized bilateral perirenal fibrosis. Surgery 2011; 151: 630-1.
Triantopoulou C, Rizos S, Bourli A, Koulentianos E, Dervenis C. Localized unilateral perirenal fibrosis: CT and MRI appearances. Eur Radiol 2002; 12: 2743-6.
Ergen FB, Arslan EB, Turkbey B, Akinci D, Akata D. Unilateral perirenal fibrosis. J Comput Assist Tomogr 2005; 29: 477-80.
Scheel PJ Jr, Feeley N. Retroperitoneal fibrosis: the clinical, laboratory, and radiographic presentation. Medicine (Baltimore). 2009; 88: 202-7.
Pőlzl G, Lhotta K, Tiefenhalter M, Smekal A, Müller S. Bilateral perirenal fluid accumulation associated with Eisenmenger’s syndrome. Nephrol Dial Transplant 2004; 19: 1928-9.
Van Bommel E, Siems C, Hak L, van der Veer S, Hendriksz T. Long-term renal and patient outcome in idiopathic retroperitoneal fibrosis treated with prednisone. Am J Kid Dis 2007; 49: 615-25.
van Bommel EF, Pelkmans LG, van Damme H, Hendriksz TR. Long-term safety and efficacy of a tamoxifen-based treatment strategy for idiopathic retroperitoneal fibrosis. Eur J Intern Med 2012, http://dx.doi.org/10.1016/j.ejim.2012.11.010.
Vaglio A, Greco P, Palmisano A, Alberici F, Maggiore U, Feretti S, et al. Prednisone versus tamoxifen in patients with idiopathic retroperitoneal fibrosis: an open-label randomised controlled trial. Lancet 2011; 378: 338-46.
The Author transfers to the Publisher (Zdravniški vestnik/Slovenian Medical Journal) all economic copyrights following form Article 22 of the Slovene Copyright and Related Rights Act (ZASP), including the right of reproduction, the right of distribution, the rental right, the right of public performance, the right of public transmission, the right of public communication by means of phonograms and videograms, the right of public presentation, the right of broadcasting, the right of rebroadcasting, the right of secondary broadcasting, the right of communication to the public, the right of transformation, the right of audiovisual adaptation and all other rights of the author according to ZASP.
The aforementioned rights are transferred non-exclusively, for an unlimited number of editions, for the term of the statutory
The Author can make use of his work himself or transfer subjective rights to others only after 3 months from date of first publishing in the journal Zdravniški vestnik/Slovenian Medical Journal.
The Publisher (Zdravniški vestnik/Slovenian Medical Journal) has the right to transfer the rights, acquired parties without explicit consent of the Author.
The Author consents that the Article be published under the Creative Commons BY-NC 4.0 (attribution-non-commercial) or comparable licence.
